Lisanti Capital Growth’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-138,830	Closed	-$3.97M	–	141
2024 Q2	$3.97M	Buy	+138,830	New	+$3.95M	0.95%	50
2022 Q3	–	Sell	-130,873	Closed	-$7.63M	–	130
2022 Q2	$7.63M	Sell	130,873 -171,540	-57%	-$11.2M	1.04%	37
2022 Q1	$23.1M	Buy	302,413 +178,428	+144%	+$11.9M	2.59%	3
2021 Q4	$7.46M	Buy	123,985 +92,060	+288%	+$5.08M	1.08%	33
2021 Q3	$1.79M	Buy	31,925 +10,560	+49%	+$609K	0.26%	120
2021 Q2	$1.3M	Sell	21,365 -161,740	-88%	-$10.2M	0.16%	127
2021 Q1	$12.8M	Buy	+183,105	New	+$13.1M	1.65%	12
2020 Q4	–	Sell	-168,482	Closed	-$10.1M	–	139
2020 Q3	$10.1M	Buy	168,482 +94	+0.1%	+$5.46K	1.88%	7
2020 Q2	$8.84M	Buy	168,388 +59,709	+55%	+$2.5M	1.8%	7
2020 Q1	$3.64M	Buy	108,679 +5,530	+5%	+$230K	1.2%	30
2019 Q4	$4.67M	Buy	103,149 +7,779	+8%	+$330K	1.24%	33
2019 Q3	$3.63M	Sell	95,370 -23,250	-20%	-$928K	1.18%	34
2019 Q2	$5.16M	Buy	118,620 +46,615	+65%	+$1.98M	1.68%	20
2019 Q1	$2.74M	Sell	72,005 -31,185	-30%	-$1.22M	0.97%	41
2018 Q4	$4.44M	Buy	103,190 +42,575	+70%	+$1.99M	1.79%	15
2018 Q3	$2.98M	Buy	+60,615	New	+$2.62M	1.03%	44
2017 Q3	–	Sell	-16,700	Closed	-$797K	–	124
2017 Q2	$797K	Buy	16,700 +6,380	+62%	+$296K	0.53%	84
2017 Q1	$471K	Buy	+10,320	New	+$446K	0.67%	75
2016 Q1	–	Sell	-24,035	Closed	-$1.85M	–	107
2015 Q4	$1.85M	Buy	+24,035	New	+$1.36M	1.94%	6
2014 Q4	–	Sell	-48,280	Closed	-$4.68M	–	101
2014 Q3	$4.68M	Sell	48,280 -2,250	-4%	-$219K	2.35%	2
2014 Q2	$4.64M	Sell	50,530 -835	-2%	-$63.6K	2.08%	4
2014 Q1	$3.6M	Sell	51,365 -630	-1%	-$42.9K	1.55%	15
2013 Q4	$2.99M	Sell	51,995 -19,765	-28%	-$1.04M	1.26%	26
2013 Q3	$3.45M	Buy	71,760 +41,725	+139%	+$1.52M	1.57%	17
2013 Q2	$1.02M	Buy	+30,035	New	+$869K	0.49%	79